Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Global Clinical Risk Grouping Solutions Market Size study, by Product (Scorecards & Visualization Tools, Dashboard Analytics Solutions, Risk Reporting Solutions), by Deployment (Private Cloud, Public Cloud, Hybrid Cloud), by End-User (Hospitals, Payers, Ambulatory Care Centers, Others) and Regional Forecasts 2019-2026

  • BIZ3510743
  • 200 Pages
  • February 2020
  • Healthcare
Download Sample    Get Discount   
 
Global Clinical Risk Grouping Solutions Market is valued approximately at USD 369.70 million in 2018 and is anticipated to grow with a healthy growth rate of more than 15.5% over the forecast period 2019-2026. Clinical risk grouping solutions are software solutions which are mainly developed to enhance the overall clinical operations of a facility by classifying patients in groups based on the severity of their necessity and the accessibility of resources available with the facility. This solution emphasizes on examining the patient data, facility data, resources availability and delivers conclusive insights in the form of insights with the help of several technological implementations, such as bigdata, machine learning and artificial intelligence (AI). Rising consumer awareness regarding risk management, increasing utilization of big data, and high demand for the reduction of rising healthcare expenditures are the few factors responsible for high CAGR of the market over the forecast period. Moreover, increasing physician burnout due to documentation needs along with increasing focus on AI and machine learning are few factors likely to create lucrative growth opportunities to the growth of market in the forecasting years. However, a lack of infrastructure for supporting the clinical risk grouping solutions technology is one of the major factor anticipated to limiting the growth of global Clinical Risk Grouping Solutions market during the forecast period.

The regional analysis of global Clinical Risk Grouping Solutions Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growing focus on quality care, increasing focus on population health management, and cost containment in the healthcare industry across the region. Also, a highly suitable healthcare IT infrastructure and high adoption of clinical risk grouping solutions by healthcare payers are further supporting the growth of clinical risk grouping solutions in this region. However, Asia-Pacific is anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as the wide presence of a larger patient pool demanding better healthcare at lower costs, economic growth, rising aging population and the advent of big data in healthcare would be influencing the growth of the market in the Asia-Pacific region.

Major market player included in this report are:

3M Company

Cerner Corporation

Nuance Communications

Conduent Inc.

HBI Solutions, Inc.

4S Information Systems Ltd.

Johns Hopkins University

Perahealth, Inc.

Health Catalyst Inc.

Evolent Health

Optum Inc. (A Subsidiary of Unitedhealth Group Inc.)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Scorecards & Visualization Tools

Dashboard Analytics Solutions

Risk Reporting Solutions

By Deployment:

Private Cloud

Public Cloud

Hybrid Cloud

By End-User:

Hospitals

Payers

Ambulatory Care Centers

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017

Base year – 2018

Forecast period – 2019 to 2026

Target Audience of the Global Clinical Risk Grouping Solutions Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Million)

1.2.1. Clinical Risk Grouping Solutions Market, by Product, 2017-2026 (USD Million)

1.2.2. Clinical Risk Grouping Solutions Market, by Deployment, 2017-2026 (USD Million)

1.2.3. Clinical Risk Grouping Solutions Market, by End-User, 2017-2026 (USD Million)

1.2.4. Clinical Risk Grouping Solutions Market, by Region, 2017-2026 (USD Million)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Clinical Risk Grouping Solutions Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Clinical Risk Grouping Solutions Market Dynamics

3.1. Clinical Risk Grouping Solutions Market Impact Analysis (2018-2026)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Clinical Risk Grouping Solutions Market: Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Clinical Risk Grouping Solutions Market, by Product

5.1. Market Snapshot

5.2. Global Clinical Risk Grouping Solutions Market by Product, Performance - Potential Analysis

5.3. Global Clinical Risk Grouping Solutions Market Estimates & Forecasts by Product 2016-2026 (USD Million)

5.4. Clinical Risk Grouping Solutions Market, Sub Segment Analysis

5.4.1. Scorecards & Visualization Tools

5.4.2. Dashboard Analytics Solutions

5.4.3. Risk Reporting Solutions

Chapter 6. Global Clinical Risk Grouping Solutions Market, by Deployment

6.1. Market Snapshot

6.2. Global Clinical Risk Grouping Solutions Market by Deployment, Performance - Potential Analysis

6.3. Global Clinical Risk Grouping Solutions Market Estimates & Forecasts by Deployment, 2016-2026 (USD Million)

6.4. Clinical Risk Grouping Solutions Market, Sub Segment Analysis

6.4.1. Private Cloud

6.4.2. Public Cloud

6.4.3. Hybrid Cloud

Chapter 7. Global Clinical Risk Grouping Solutions Market, by End-User

7.1. Market Snapshot

7.2. Global Clinical Risk Grouping Solutions Market by End-User, Performance - Potential Analysis

7.3. Global Clinical Risk Grouping Solutions Market Estimates & Forecasts by End-User, 2016-2026 (USD Million)

7.4. Clinical Risk Grouping Solutions Market, Sub Segment Analysis

7.4.1. Hospitals

7.4.2. Payers

7.4.3. Ambulatory Care Centers

7.4.4. Others

Chapter 8. Global Clinical Risk Grouping Solutions Market, Regional Analysis

8.1. Clinical Risk Grouping Solutions Market, Regional Market Snapshot

8.2. North America Clinical Risk Grouping Solutions Market

8.2.1. U.S. Clinical Risk Grouping Solutions Market

8.2.1.1. Product breakdown estimates & forecasts, 2016-2026

8.2.1.2. Deployment breakdown estimates & forecasts, 2016-2026

8.2.1.3. End-User breakdown estimates & forecasts, 2016-2026

8.2.2. Canada Clinical Risk Grouping Solutions Market

8.3. Europe Clinical Risk Grouping Solutions Market Snapshot

8.3.1. U.K. Clinical Risk Grouping Solutions Market

8.3.2. Rest of Europe Clinical Risk Grouping Solutions Market

8.4. Asia-Pacific Clinical Risk Grouping Solutions Market Snapshot

8.4.1. China Clinical Risk Grouping Solutions Market

8.4.2. India Clinical Risk Grouping Solutions Market

8.4.3. Japan Clinical Risk Grouping Solutions Market

8.4.4. Rest of Asia Pacific Clinical Risk Grouping Solutions Market

8.5. Latin America Clinical Risk Grouping Solutions Market Snapshot

8.5.1. Brazil Clinical Risk Grouping Solutions Market

8.5.2. Mexico Clinical Risk Grouping Solutions Market

8.6. Rest of The World Clinical Risk Grouping Solutions Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies

9.2. Company Profiles

9.2.1. 3M Company

9.2.1.1. Key Information

9.2.1.2. Overview

9.2.1.3. Financial (Subject To Data Availability)

9.2.1.4. Product Summary

9.2.1.5. Recent Developments

9.2.2. Cerner Corporation

9.2.3. Nuance Communications

9.2.4. Conduent Inc.

9.2.5. HBI Solutions, Inc.

9.2.6. 4S Information Systems Ltd.

9.2.7. Johns Hopkins University

9.2.8. Perahealth, Inc.

9.2.9. Health Catalyst Inc.

9.2.10. Evolent Health

9.2.11. Optum Inc. (A Subsidiary of Unitedhealth Group Inc.)

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.2. Research Attributes

10.3. Research Assumption

List of Tables

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET

TABLE 3. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD MILLION)

TABLE 7. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY PRODUCT 2016-2026 (USD MILLION)

TABLE 8. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY DEPLOYMENT 2016-2026 (USD MILLION)

TABLE 9. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY END-USER 2016-2026 (USD MILLION)

TABLE 10. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 11. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 12. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 13. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 14. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 15. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 16. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 17. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 18. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 19. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 20. U.S. CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 21. U.S. CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 22. U.S. CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 23. CANADA CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 24. CANADA CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 25. CANADA CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 26. UK CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 27. UK CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 28. UK CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 29. GERMANY CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 30. GERMANY CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 31. GERMANY CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 32. ROE CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 33. ROE CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 34. ROE CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 35. CHINA CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 36. CHINA CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 37. CHINA CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 38. INDIA CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 39. INDIA CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 40. INDIA CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 41. JAPAN CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 42. JAPAN CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 43. JAPAN CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 44. ROAPAC CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 45. ROAPAC CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 46. ROAPAC CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 47. BRAZIL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 48. BRAZIL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 49. BRAZIL CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 50. MEXICO CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 51. MEXICO CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 52. MEXICO CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 53. ROLA CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 54. ROLA CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 55. ROLA CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 56. ROW CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD MILLION)

TABLE 57. ROW CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

TABLE 58. ROW CLINICAL RISK GROUPING SOLUTIONS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD MILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
View Details
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
View Details
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950
View Details
 
View More
 

Client Testimonials

2026 © Copyright Big Market Research